Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | TXNRD1 | Q16881 | 6/20 | 0.77 |
| ▸ | TXNRD3 | Q86VQ6 | 6/20 | 0.77 |
| ▸ | TXNRD2 | Q9NNW7 | 6/20 | 0.77 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alfadex SCHEMBL21134960 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL25455463 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL24109285 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL20533920 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL25455531 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL23188277 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL24109286 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL25455476 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL23188251 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL20998969 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025137451-A1 | APPARATUS AND METHOD FOR DETECTION OF METAL IONS AND PEAS POLLUTANTS IN A SAMPLE | 12-15 MOLECULAR DIAGNOSTICS, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-10851469-B2 | Synthesis of core-shell nanoparticles and applications of said nanoparticles for surface enhanced Raman scattering | UNIVERSITE PARIS DIDEROT (FR) | 2020-12-01 | — | — | US | claimed |
| EP-3526375-B1 | SYNTHESIS OF CORE-SHELL NANOPARTICLES AND USES OF SAID NANOPARTICLES FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY | UNIV PARIS DIDEROT (FR) | 2020-06-24 | — | — | EP | claimed |
| US-20200048788-A1 | SYNTHESIS OF CORE-SHELL NANOPARTICLES AND APPLICATIONS OF SAID NANOPARTICLES FOR SURFACE ENHANCED RAMAN SCATTERING | UNIVERSITE PARIS DIDEROT (FR) | 2020-02-13 | — | — | US | claimed |
| EP-3526375-A1 | SYNTHESIS OF CORE-SHELL NANOPARTICLES AND USES OF SAID NANOPARTICLES FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY | Université Paris Diderot (FR) | 2019-08-21 | — | — | EP | claimed |
| US-8435966-B2 | Associations of xanthogenates and cyclodextrins, and their use | BIOSPHINGS AG (DE) | 2013-05-07 | — | — | US | claimed |
| US-20100240606-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BIOSPHINGS AG (DE) | 2010-09-23 | — | — | US | claimed |
| CN-101522612-A | Associations of xanthogenates and cyclodextrins, and their use | BIOSPHINGS AG (DE) | 2009-09-02 | — | — | CN | claimed |
| EP-2001840-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BioSphings AG (DE) | 2008-12-17 | — | — | EP | claimed |
| WO-2007112828-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BIOSPHINGS AG (DE) | 2007-10-11 | — | — | WO | claimed |
| US-20260137805-A1 | SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY | Oculis Operations Sàrl (CH) | 2026-05-21 | — | — | US | disclosed |
| EP-4391840-B1 | MEDICAL LIQUID COMPOSITION FOR AERIAL ADMINISTRATION | NATURAL ACAD S R L (IT) | 2026-05-06 | — | — | EP | disclosed |
| US-12610957-B2 | Compositions and methods of controlling pests | PERTINENT ECO-SOLUTIONS INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-12551475-B2 | Methods and compositions for treating RNA viral infections | MODEL MEDICINES, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| EP-4687838-A2 | UNIT DOSAGE COMPOSITION COMPRISING MIDAZOLAM | B. Braun Melsungen AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| US-20070092544-A1 | Natural insect repellant | INT'L ALLY, INC. | 2007-04-26 | — | — | US | disclosed |
| US-20070088508-A1 | Cocrystallization methods | APTUIT (WEST LAFAYETTE), LLC | 2007-04-19 | — | — | US | disclosed |
| US-20070049496-A1 | LIMONENE-CONTAINING HERBICIDE COMPOSITIONS, HERBICIDE CONCENTRATE FORMULATIONS AND METHODS FOR MAKING AND USING SAME FOR ORGANIC PRODUCTION | AVENGER PRODUCTS, LLC | 2007-03-01 | — | — | US | disclosed |
| US-6824707-B2 | MIXTURE CONTAINING DOPE | CLARIANT INTERNATIONAL LTD. (CH) | 2004-11-30 | — | — | US | disclosed |
| US-20030127627-A1 | Active matrix liquid crystal device and smectic liquid crystal mixture | CLARIANT INTERNATIONAL LTD. | 2003-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137805-A1 | SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY | CFD, PDE6D, PDE6H | ALDH1A1 4332/4885TSHR 3138/4885LMNA 3427/4885 |
| US-12551475-B2 | Methods and compositions for treating RNA viral infections | SARS1, EIF2AK2, SNRPE | ALDH1A1 2656/4885TSHR 1607/4885LMNA 1401/4885 |
| US-12610957-B2 | Compositions and methods of controlling pests | DGAT2, DGAT1, DAGLB | ALDH1A1 2856/4885TSHR 3322/4885LMNA 611/4885 |
| US-20100240606-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | HLA-DRB1, CXCR3, ANTXR2 | ALDH1A1 4475/4885TSHR 2243/4885LMNA 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.